Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation
暂无分享,去创建一个
D. A. Gomes | D. Gomes | Thaís M M Martins | Dawidson A Gomes | Ana CC Paula | Thaís MM Martins | Alessandra Zonari | Soraia PPJ Frade | Patrícia C Angelo | Alfredo M Goes | A. Goes | Alessandra Zonari | A. C. Paula | P. C. Angelo | S. P. Frade | A. Paula
[1] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[2] K. Drzewiecki,et al. Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. , 2013, Cytotherapy.
[3] A. Friedenstein,et al. THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.
[4] Seung Il Kim,et al. Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy. , 2014, Experimental and molecular pathology.
[5] S. Gronthos,et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Yamaguchi,et al. Constitutive Expression of Human Telomerase Enhances the Proliferation Potential of Human Mesenchymal Stem Cells , 2012, BioResearch open access.
[7] W. Mars,et al. Bone marrow as a potential source of hepatic oval cells. , 1999, Science.
[8] Weiqing Wang,et al. Gene expression profiles of phaeochromocytomas with ERBB2 overexpression reveal a new molecular mechanism tumourigenicity , 2012, Clinical endocrinology.
[9] V. Beneš,et al. Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process , 2008, PloS one.
[10] B. Cousin,et al. Adipose-derived stromal cells: Their identity and uses in clinical trials, an update. , 2011, World journal of stem cells.
[11] P. Lønning,et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.
[12] H. Lorenz,et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.
[13] A. Sbarbati,et al. Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. , 2008, Stem cells and development.
[14] T. Jensen,et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells , 2002, Nature Biotechnology.
[15] B. Nilsson,et al. Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells? , 2014, PloS one.
[16] A. Cometa,et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute , 2007, Journal of cellular physiology.
[17] R. Walker,et al. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. , 1997, Blood.
[18] Kathryn A. O’Donnell,et al. Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis , 2006, Molecular and Cellular Biology.
[19] H. Harn,et al. Genetic and Epigenetic Instability of Stem Cells , 2014, Cell transplantation.
[20] F. Guilak,et al. Human adipose-derived cells: an update on the transition to clinical translation. , 2012, Regenerative medicine.
[21] A. Cometa,et al. Ex vivo expansion of mesenchymal stromal cells. , 2011, Best practice & research. Clinical haematology.
[22] A. Cometa,et al. Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms , 2010 .
[23] K. Masuda,et al. HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study , 2015, Gastric Cancer.
[24] D. García-Olmo,et al. Treatment of enterocutaneous fistula in Crohn’s Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion , 2008, International Journal of Colorectal Disease.
[25] L. Muul,et al. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. , 2002, Human gene therapy.
[26] D. Balomenos,et al. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. , 2009, Neoplasia.
[27] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[28] R. Suuronen,et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. , 2009, International journal of oral and maxillofacial surgery.
[29] M. Lindberg,et al. Adipose Tissue , 2018 .
[30] Louis Casteilla,et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). , 2013, Cytotherapy.
[31] H. Klüter,et al. Human AB Serum and Thrombin‐Activated Platelet‐Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue , 2007, Stem cells.
[32] J. Laine,et al. N‐Glycolylneuraminic Acid Xenoantigen Contamination of Human Embryonic and Mesenchymal Stem Cells Is Substantially Reversible , 2007, Stem cells.
[33] J. Cigudosa,et al. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. , 2010, Experimental cell research.
[34] R. Bjerkvig,et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. , 2010, Cancer research.
[35] K. Tarte,et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. , 2013, Cytotherapy.
[36] Hélène Rouard,et al. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. , 2010, Blood.
[37] Su-jin Kim,et al. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. , 2008, Stem cells and development.
[38] Shu-Ching Hsu,et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] Katrine Frønsdal,et al. In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability , 2005, Stem cells.
[40] F. Gage,et al. Human embryonic stem cells express an immunogenic nonhuman sialic acid , 2005, Nature Medicine.
[41] R. Suuronen,et al. The Potential of Adipose Stem Cells in Regenerative Medicine , 2011, Stem Cell Reviews and Reports.
[42] H. Northoff,et al. Expression of blood group genes by mesenchymal stem cells , 2011, British journal of haematology.
[43] P. Bugert,et al. Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. , 2010, Tissue engineering. Part A.
[44] Y. Ishii,et al. Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. , 2009, Biochemical and biophysical research communications.
[45] D. Strunk,et al. Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow , 2009, Stem cells.
[46] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[47] Min Zhu,et al. Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.
[48] M. Miyazaki,et al. Effect of c-fos overexpression on development and proliferation of peritoneal B cells. , 2004, International immunology.
[49] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Evan,et al. Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle. , 1985, EMBO Journal.
[51] R. Hruban,et al. Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo , 2011, Oncotarget.
[52] L. Griffith,et al. Growth factor regulation of proliferation and survival of multipotential stromal cells , 2010, Stem Cell Research & Therapy.
[53] L. Young,et al. Mitogenic factors present in serum but not in plasma. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. A. Gomes,et al. Human serum is a suitable supplement for the osteogenic differentiation of human adipose-derived stem cells seeded on poly-3-hydroxibutyrate-co-3-hydroxyvalerate scaffolds. , 2013, Tissue engineering. Part A.
[55] Y. Nie,et al. The Effect of miRNA‐122 in Regulating Fat Deposition in a Cell Line Model , 2014, Journal of cellular biochemistry.
[56] M. Paz,et al. Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation , 2008, PloS one.
[57] Javier León,et al. Myc and cell cycle control. , 2015, Biochimica et biophysica acta.
[58] R. Weinberg,et al. Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.
[59] Baojin Fu,et al. Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation , 2006, Stem cells.
[60] Jürgen Frank,et al. Serum-free cell culture: the serum-free media interactive online database. , 2010, ALTEX.
[61] G. Rechavi,et al. Serum Free Cultured Bone Marrow Mesenchymal Stem Cells as a Platform to Characterize the Effects of Specific Molecules , 2010, PloS one.
[62] Moustapha Kassem,et al. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. , 2009, Stem cells and development.
[63] H. Lawce,et al. The AGT cytogenetics laboratory manual , 2017 .
[64] O. Yli-Harja,et al. Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. , 2010, Tissue engineering. Part A.
[65] A. C. D. de Paula,et al. Alkaline Phosphatase Expression/Activity and Multilineage Differentiation Potential are the Differences Between Fibroblasts and Orbital Fat-Derived Stem Cells – A Study in Animal Serum-Free Culture Conditions , 2014, Stem Cell Reviews and Reports.
[66] G Gstraunthaler,et al. Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.
[67] G. Semenza,et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.
[68] M. Kassem,et al. Human Serum is as Efficient as Fetal Bovine Serum in Supporting Proliferation and Differentiation of Human Multipotent Stromal (Mesenchymal) Stem Cells In Vitro and In Vivo , 2011, Stem Cell Reviews and Reports.
[69] F. Guilak,et al. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells , 2010, Stem Cell Research & Therapy.
[70] E. Tulchinsky,et al. Fos family members: regulation, structure and role in oncogenic transformation. , 2000, Histology and histopathology.
[71] I. Tan,et al. Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH. , 2014, Cancer letters.
[72] D. Gomes,et al. Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. , 2011, Biochemical and biophysical research communications.
[73] U. Leimer,et al. Choosing the right type of serum for different applications of human adipose tissue-derived stem cells: influence on proliferation and differentiation abilities. , 2014, Cytotherapy.
[74] Uma Lakshmipathy,et al. Development and Characterization of a Clinically Compliant Xeno‐Free Culture Medium in Good Manufacturing Practice for Human Multipotent Mesenchymal Stem Cells , 2012, Stem cells translational medicine.
[75] A. Katz,et al. Low serum and serum-free culture of multipotential human adipose stem cells. , 2007, Cytotherapy.
[76] Sanjin Zvonic,et al. Immunophenotype of Human Adipose‐Derived Cells: Temporal Changes in Stromal‐Associated and Stem Cell–Associated Markers , 2006, Stem cells.
[77] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .
[78] Anthony Atala,et al. Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.
[79] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[80] Johannes Gerdes,et al. The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.
[81] D. Kaigler,et al. Development of a serum‐free system to expand dental‐derived stem cells: PDLSCs and SHEDs , 2011, Journal of cellular physiology.
[82] A. Kohara,et al. Growth factor-defined culture medium for human mesenchymal stem cells. , 2011, The International journal of developmental biology.
[83] A. Hmadcha,et al. Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use. , 2014, Stem cells and development.